Fluticasone furoate for the treatment of childhood asthma
Explore this paper's citation graph
Summary
The introduction of once-daily inhaled fluticasone furoate, either alone or in combination with the long-acting β-agonist, vilanterol, simplifies chronic asthma therapy and may improve adherence and as a result, outcomes in this vulnerable population.
- Type
- review
- Published
- 2015-07-04
- Cited by
- 2
- References
- 51
- OpenAlex
- https://openalex.org/W1800703307
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:10060468
Keywords
Fluticasone propionate, Medicine, Asthma, Pediatrics, Inhaled corticosteroids
References
- Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study
- GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
- Prolonged protection of the new inhaled corticosteroid fluticasone furoate against AMP hyperresponsiveness in patients with asthma
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5–11 years with persistent asthma: A randomized trial
- Growth velocity reduced with once-daily fluticasone furoate nasal spray in prepubescent children with perennial allergic rhinitis.
- Adolescents’ Perception of Asthma Symptoms and Health Service Utilization
- Medication non-adherence and asthma treatment cost
- Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids.
- Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- Delivery of inhaled drugs for infants and small children: a commentary on present and future needs.
- Delivery of inhalation drugs to children for asthma and other respiratory diseases.
- Adherence with Preventive Medication in Childhood Asthma
- Long-acting fluticasone furoate has a superior pharmacological profile to fluticasone propionate in human respiratory cells.
- Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
- Asthma in Pediatric Patients: Unmet Need and Therapeutic Options
- Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial.
- Childhood chronic health conditions and educational attainment: a social ecological approach.
- Prolonged Treatment with Inhaled Corticosteroids does not Normalize High Activity of Matrix Metalloproteinase-9 in Exhaled Breath Condensates of Children with Asthma
- The efficacy of once-daily fluticasone furoate/vilanterol in asthma is comparable with morning or evening dosing.
Cited by
Related papers
- Unexpected Effects of Inhaled Fluticasone in an HIV Patient with Asthma
- Adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma
- Efficacy and safety of once-daily fluticasone furoate 50 mcg in adults with persistent asthma: a 12-week randomized trial
- Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma.
- Do inhaled steroids have similar efficacy? A case of bronchial asthma suggesting different efficacy of inhaled glucocorticosteroids
- The therapeutic effects of inhaled long-acting beta2-adrenergics (LABA) and corticosteroids (ICS) are not affected by their inhalation sequence in moderate/persistent asthma.
- Real-world efficacy and problems of once-daily use of inhaled steroid (fluticasone furoate) combined with long-acting beta-2 agonist (vilanterol) in Japanese patients with asthma
- [Inhaled corticosteroids: first-line therapy in asthma].
- The Effect of an Electronic Monitoring Device With Audiovisual Reminder Function on Adherence to Inhaled Corticosteroids and School Attendance in Children With Asthma: A Randomised Controlled Trial (Australian New Zealand Clinical Trials Registry # ACTRN12613001353785)
- The use of inhaled corticosteroids for persistent asthma in infants and young children.